Tus kws kho mob
P39-25 New Medical and Behavioral Health Policy Management Updates, Effective September 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2801 - 2810 ntawm 4303
Tus kws kho mob
QP60-25 MHCP Pharmacy Benefit Exclusion for Emrelis™, Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP59-25 Commercial Pharmacy Benefit Exclusion for Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP58-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP57-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP56-25 MHCP Enhanced Authorization Submissions through Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP55-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025